Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2007
-
By Donald Zuhn — Last summer, we reported that Roche had made an offer to acquire Ventana Medical Systems, Inc. for $75 per share, or approximately $3 billion. In response, Ventana’s Board of Directors announced that it had determined that Roche’s offer was "inadequate in multiple respects and contrary to the best interests…
-
By Kevin E. Noonan — The following is part of a continuing series on how to address the very real problems facing the U.S. Patent and Trademark Office. A day after the day of rejoicing for inventors, patent practitioners, examiners, and seemingly all of civilization, fair-minded people will concede that the U.S. Patent…
-
By Donald Zuhn — The following is part of a continuing series on how to address the very real problems facing the U.S. Patent and Trademark Office. A day after the day of rejoicing for inventors, patent practitioners, examiners, and seemingly all of civilization, fair-minded people will concede that the U.S. Patent and…
-
By Kevin E. Noonan — It’s getting harder and harder for patentees, applicants, and their counsel to know who their friends are. First there was the silence of the major industry groups in the face of the new continuation and claim limitations rules since enjoined by Judge Cacheris in the Federal District Court…
-
The biotechnology, chemical, and pharmaceutical technology groups at the U.S. Patent and Trademark Office are scheduled to hold the next quarterly meeting on December 4, 2007. The proposed topics for discussion include: Morning Session (9:00-noon EST) Patent Corp Security Program — (presenter: Don Hajec, Director, TC3600) KSR Overview, Court Opinion and PTO Guidelines, and Technology…
-
By Kevin E. Noonan — The following is part of a continuing series on how to address the very real problems facing the U.S. Patent and Trademark Office. A day after the day of rejoicing for inventors, patent practitioners, examiners, and seemingly all of civilization, fair-minded people will concede that the U.S. Patent…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Alcon Manufacturing Ltd. et al. v. Barr Laboratories Inc.1:07-cv-00718; filed November 7, 2007 in the District Court of Delaware Infringement of U.S.…
-
November 13-15, 2007 – Pharma and Biotech Collaborative Agreements (American Conference Institute) – New York, NY*** December 3, 2007 – 18th Annual Conference on U.S. Patent and Trademark Office Law and Practice – PTO Day (Intellectual Property Owners Association and U.S. Patent and Trademark Office) – Washington, D.C. January 9, 2008 – Patent Claim Construction…
-
By Christopher P. Singer — On October 30, 2007, Ocean Tomo Auctions, LLC (the auctions arm of Ocean Tomo LLC) announced the results of its live IP auction, held on October 25, 2007 in Chicago. The announcement indicated that sales from the open bidding session and transactions that immediately followed the open bidding…
-
One year ago today, the authors listed on the sidebar to the left — Donald Zuhn, Kevin Noonan, Jason Derry, Chris Singer, and Sherri Oslick — began publishing Patent Docs, a weblog focusing on recent developments in biotech and pharma patent law. Chris Singer penned the first new Patent Docs article, which discussed the electronic…
Patent Docs 